D-1391-2019 Class III Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-1391-2019 was initiated by Teligent Pharma, Inc. on May 20, 2019 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Jan 27, 2025). Affected quantity: 9360 tubes.

Recall details

Product Type
Drugs
Report Date
Jun 26, 2019
Initiation Date
May 20, 2019
Termination Date
Jan 27, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9360 tubes

Product description

Betamethasone Dipropionate Ointment USP, 0.05%* (Augmented), a) 15 gram (NDC 52565-019-15) and b) 50 gram (NDC 52565-019-51) tubed, Rx Only, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 06310

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide

Code information

Lot 11852, exp date 08/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1391-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1391-2019. Report a data issue: hello@regdatalab.com.